Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Essity AB ( ($SE:ESSITY.B) ) is now available.
Essity ended 2025 with higher margins and profitability despite lower reported sales, as currency effects weighed on the top line but underlying demand and pricing remained resilient. In the fourth quarter, net sales fell 8.2% to SEK 34.7bn and organic sales declined 1.1%, yet EBITA excluding items affecting comparability rose 3% and the margin improved to 14.7%, driving an 11% increase in profit for the period. For the full year, net sales decreased 4.8% to SEK 138.5bn, although net sales excluding currency translation effects increased and organic sales grew 0.9%, while EBITA was broadly flat and margins edged higher. Return on capital employed strengthened and earnings per share from continuing operations increased, and the board proposed a 6% dividend hike, signalling confidence in cash generation and balance sheet strength despite a sharp year-on-year decline in profit for total operations due to non-recurring effects in the prior year.
The most recent analyst rating on ($SE:ESSITY.B) stock is a Hold with a SEK274.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.
More about Essity AB
Essity AB is a global hygiene and health company that develops, produces and sells tissue, personal care and professional hygiene products. Its portfolio includes consumer tissue, incontinence products, baby and feminine care, and solutions for professional and medical hygiene, with operations focused on large international retail and institutional markets.
Average Trading Volume: 1,254,885
Technical Sentiment Signal: Strong Buy
Current Market Cap: SEK187.4B
Learn more about ESSITY.B stock on TipRanks’ Stock Analysis page.